JointHealth™ express   February 1, 2018

Biosimilars in Canada: What inflammatory arthritis patients need to know

Arthritis Consumer Experts (ACE) is pleased to announce the publication of its latest educational webinar titled “Biosimilars in Canada: What inflammatory arthritis patients need to know”. Co-presented by Dr. John Esdaile, Scientific Director, Arthritis Research Canada and Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts, the webinar covers the latest biosimilar research, patient education information and public drug plan reimbursement policy development:
  • Safety, efficacy and immunogenicity
  • Latest clinical research
  • Clinical and patient experiences
  • Safety and efficacy monitoring
  • Medical and policy transitioning
  • Societal benefit
The Webinar gives inflammatory arthritis patients the important facts and information tools they need to power and support their conversations with their rheumatologists and other health care providers and ensure evidence-based continuity of care.

Click here to view this important new webinar in our educational series. We also encourage you to visit ACE’s Biosimilar•Exchange, the world’s only patient written, research informed web site on biosimilars – free from commercial bias or branding.